LA HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Many celebrities lose their pounds of flesh to plastic surgery for little gain.
Michael Levine gets under stars’ skin as he slices and dices Hollywood’s love of plastic surgery.
BIOTECH: CytRx’s stock offering flops in industry’s biggest sell-off in two years.
CytRx’s shot-in-arm stock offering swamped by tsunami of an industry sell-off.
Xencor Inc., a Monrovia company developing antibody-based drugs to treat cancer, autoimmune diseases and other conditions, on Friday filed for an initial public offering.
Health Net Inc. has signed a contract with Prime Healthcare Services to add 14 hospitals to its network.
UCLA Health System and the Motion Picture & Television Fund on Wednesday said UCLA plans to take over operations and leases on six Fund health clinics that now serve entertainment industry workers.
City of Hope and Providence Health & Services on Wednesday announced a partnership that will add City of Hope's cancer patient care expertise to Providence’s Los Angeles-area hospitals.
LTC Properties Inc. on Tuesday said that it plans to spend $19.6 million to construct communities in Colorado for elderly patients with memory disorders.
Kythera Biopharmaceuticals Inc. on Monday announced a $100 million stock offering as it prepares to seek FDA approval of its groundbreaking drug that reduces double chins.
OP-ED: Individual payer finds pricey policies and few choices on California’s health care exchange website.
California’s health care exchange gets a poor early prognosis from Steve Duchesne.
Alma Morales Riojas gags on Herbalife’s claims about the distributors of its nutritional supplements.
Health care real estate firm HCP Inc. on Thursday said it fired longtime chief executive James Flaherty.
Molina Healthcare Inc. on Thursday said that its board has authorized the repurchase of up to $50 million worth of the company's common stock.
Amgen Inc. has completed its tender offer to purchase all outstanding shares of Onyx Pharmaceuticals Inc. at $125 a share, or a total price of $9.7 billion.
Cities’ concerns leave e-cigarette shops up in air
All the new e-cigarette shops are up in the air as local authorities try to figure out how to regulate vaporized nicotine.
The FDA has approved the first artificial pancreas system in the United States, a device developed at Medtronic Inc.’s Northridge facility, the company announced on Friday.